Respiratory syncytial virus vaccination in pregnancy
[See related article at www.cmaj.ca/lookup/doi/10.1503/cmaj.240780][1] Maternal RSV antibodies, transferred across the placenta, wane gradually, leaving young infants vulnerable to RSV infection.[1][2] RSVpreF is a recombinant, non-adjuvanted vaccine against the RSV prefusion F protein, given
Authors
- Bahaa Abu-Raya (ORCID: https://orcid.org/0000-0002-3528-0343)
- Pascal M. Lavoie (ORCID: https://orcid.org/0000-0002-2205-0362)
- Joanne M. Langley (ORCID: https://orcid.org/0000-0003-3270-7345)
Institutions
- Nova Scotia Health Authority (CA)
Publication Details
- Journal
- Canadian Medical Association Journal
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1503/cmaj.240773
- Citations
- 3
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- Pfizer
- Sanofi
- Moderna
- Dalhousie University
- Provincial Health Services Authority